| 541/949 | US=86 / Biol/Mol Zakeri Z, Lockshin RA. Cell dealth: history and future. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 1-11. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. MORTE CELULAR; APOPTOSE; AUTOFAGIA; MORTE CELULAR AUTOFAGICA; HISTORICO; LISOSSOMA |
| 542/949 | US=86 / Biol/Mol Tan TT, White E. Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 81-104. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. SEGMENTACAO TERAPEUTICO; VIAS DE MORTE EM CANCER; MECANISMOS; MORTE CELULAR; CELULAS CANCERIGENAS; APOPTOSE; QUIMIOTERAPIA; TERAPIA ALVO; FAMILIA BCL-2; RECEPTORES DE MORTE; INIBIDORES DO SINAL DE TRANSDUCAO |
| 543/949 | US=86 / Biol/Mol Moore VDG, Letai A. Rational design of therapeutics targeting the BCL-2 family: are some cancer cells primed for death but waiting for a final push?. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 159-75. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. MORTE CELULAR; APOPTOSE; FAMILIA BCL-2; BH3; TERAPEUTICA; PEPTIDEOS |
| 544/949 | US=86 / Biol/Mol Bialik S, Kimchi A. Autophagy and tumor suppression: recent advances in understanding the link between autophagic cell death pathways and tumor development. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 177-200. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. AUTOFAGIA; SUPRESSAO DO TUMOR; AUTOFAGICOS; VIAS DE MORTE CELULAR; DESENVOLVIMENTO DE TUMORES; MORTE CELULAR PROGRAMADA; DAPK; BECLIN 1; MTOR |
| 545/949 | US=86 / Biol/Mol Kuribayashi K, El-Deiry W. Regulation of programmed cell death by the P53 pathway. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 201-21. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. REGULACAO DA MORTE CELULAR PROGRAMADA; VIA P53; APOPTOSE; TRANSCRICAO; RECEPTORES TRAIL; MORTE CELULAR DEPENDENTES DE P53 |
| 546/949 | US=86 / Biol/Mol Fan Y, Dutta J, Gupta N, Fan G, Gélinas C. Regulation of programmed cell death by NF-kB and its role in tumorigenesis and therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 223-50. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. REGULACAO DA MORTE CELULAR; NF-KB; TUMORIGENESE; TERAPIA; APOPTOSE; NECROSE; FATOR DE TRANSCRICAO; CANCER |
| 547/949 | US=8-A / Dermatologia Kraemer KH. Heritable diseases with increased sensitivity to cellular injury. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 1508-21. ISBN 978-0-07-138076-0. DOENCAS HEREDITARIAS; SENSIBILIDADE AUMENTADA; LESAO CELULAR; XERODERMIA PIGMENTOSA; SINDROME DE COCKAYNE; TRICOTIODISTROFIA; SINDROME DE BLOOM; ANEMIA DE FANCONI; DISCERATOSE CONGENITA |
| 548/949 | US=9 / Patologia Ovalle WK, Nahirney PC. Células e tecidos: a célula. In: ___. Netter, bases da histologia. Rio de Janeiro: Elsevier, 2008. p. 1-28. ISBN 85-3522803-8. CELULAS; FUNCAO DAS CELULAS; JUNCAO INTERCELULAR; CICLO CELULAR; DIVISOES DA CELULAS |
| 549/949 | US=90 / Biol/Mol Gavard J, Gutkind JS. EGFR signaling networks: a molecular crosstalk between e-cadlherin and EGFR signaling networks. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 139-54. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1. EGFR; JUNCOES CELULARES; ADESAO CELULAR; CADERINA; CATENINA MIGRACAO; ACTINA |
| 550/949 | US=98 / Biol/Mol Lockshin RA, Zakeri Z. Historical studies of various forms of cells death. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 55-72. ISBN 978-084939192-7. |
| 551/949 | US=98 / Biol/Mol Bredesen DE. Toward a mechanistic taxonomy for programmed cell death pathways. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 73-91. ISBN 978-084939192-7. |
| 552/949 | US=98 / Biol/Mol Egger L. Caspase-independent apoptotic cell death. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 93-108. ISBN 978-084939192-7. CASPASE-INDEPENDENTE DE MORTE CELULAR POR APOPTOSE; INIBICAO DA CASPASE; SINTETICOS INIBIDORES DE CASPASES; CASPASE-MORTE CELULAR INDEPENDENTE |
| 553/949 | US=98 / Biol/Mol Madden DT. Autophagic cell death in mammalian cells. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 109-26. ISBN 978-084939192-7. MORTE CELULAR; CELULAS DE MAMIFEROS AUTOFAGICA; AUTOFAGIA E CANCER |
| 554/949 | US=98 / Biol/Mol Fan Y, Ullman E, Zong WX. The cellular decision between apoptosis and autophagy. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 127-41. ISBN 978-084939192-7. |
| 555/949 | US=98 / Biol/Mol Dawson VL, Dawson TM. Parthanatos: PARP - and AIF-dependent programmed cell death. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 143-56. ISBN 978-084939192-7. PARTHANATOS; PARP; FIA; MORTE CELULAR PROGRAMADA; POLYMERASE-1 |
| 556/949 | US=98 / Biol/Mol Campisi J. Cellular senescence and its effects on carcinogenesis. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 175-93. ISBN 978-084939192-7. SENESCENCIA CELULAR; CARCINOGENESE. EFEITOS; SENESCENCIA CELULAR E OS SEUS EFEITOS SOBRE A CARCINOGENESE; SENESCENCIA CELULAR SUPRIME CANCER; CANCER E ENVELHECIMENTO; SENESCENCIA CELULAR E CANCER |
| 557/949 | US=98 / Biol/Mol Roninson IB, Broude EV. Treatment-induced tumor cell senescence and its consequences. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 223-49. ISBN 978-084939192-7. CELULAS TUMORAIS. TRATAMENTO SENESCENCIA; ANTICARCINOGENICO; SENESCENCIA CELULAR TUMORAL |
| 558/949 | US=98 / Biol/Mol Wu DY, Wang H, Wang Q, Wu PC, Vesselle HJ. Therapy-induced cellular senescence: clinical relevance, implications, and applications. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 295-306. ISBN 978-084939192-7. INDUZIDA PELA TERAPIA SENESCENCIA CELULAR; RELEVANCIA CLINICA; IMPLICACOES E APLICACOES; SENESCENCIA CELULAR ACELERADO; ACS |
| 559/949 | US=98 / Biol/Mol Dewey WC. How do cells die after irradiation? time-lapse studies of cells in culture. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 321-32. ISBN 978-084939192-7. CELULAS MORREM APOS IRRADIACAO; LAPSO TEMPORAL; ESTUDOS DE CULTURA CELULAR |
| 560/949 | US=98 / Biol/Mol Brown JM. Modes of cell death by anticancer agents: the crucial importance of dose. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 333-41. ISBN 978-084939192-7. |